Introducing our Low GI Soba Noodles, a scientifically engineered nutritional solution designed for those prioritizing blood sugar management and overall wellness. By combining a high concentration of buckwheat (70%) with konjac and green barley, we have created a premium noodle that doesn't compromise on taste while adhering to strict dietary requirements for diabetics and health-conscious consumers.
Our product is backed by rigorous clinical validation and national patents, focusing on a "sugar-blocking" technology that ensures a low glycemic response. Whether you are managing chronic conditions like diabetes, pursuing fat reduction, or simply seeking a high-fiber, nutrient-dense alternative to traditional pasta, these Soba noodles provide a satisfying and safe culinary experience.
Detailed Parameters
| Buckwheat Content | 70% Premium Buckwheat | Glycemic Index (GI) | 42.7 (Certified Low GI) |
|---|---|---|---|
| Key Ingredients | Buckwheat, Konjac, Green Barley, Tartary Buckwheat | Patent Status | National Invention Patent |
| Certification | Beijing Institute of Nutrition Source | Dietary Fiber | High Content / High Satiety |
| Clinical Validation | Shanxi Medical University (3-Month Trial) | Primary Effect | Stabilizing & Controlling Blood Sugar |
| Target Group | Diabetics, Weight Loss, Sub-health Users | Product Category | Low Calorie Soba Noodles |
Key Advantages
Patented Sugar Block
Utilizes a national invention patent to block sugar sources, effectively reducing glycemic rise after consumption.
Clinically Proven
Validated through a 3-month clinical trial at Shanxi Medical University, proving efficacy in glucose stability.
Certified Low GI
Officially certified by the Beijing Institute of Nutrition Source with a verified GI value of 42.7.
High Satiety
Rich in dietary fiber, allowing users to feel full longer, which aids in weight management and fat reduction.
Nutrient Dense
A blend of Tartary buckwheat and green barley provides essential vitamins and minerals for sub-health recovery.
Community Validated
Successful one-year tasting programs with community doctors confirm real-world blood sugar lowering effects.
Product Gallery
Management Platforms
Quality Control
Strict adherence to food safety standards for organic and medicinal-grade raw materials.
Patented Processing
Advanced manufacturing using patented technology to optimize the low GI structure.
Health Monitoring
Integrated feedback loops based on clinical reports from medical universities.
Nutrition Auditing
Regular testing by national nutrition institutes to ensure consistent GI values.
Supply Chain
Direct sourcing of high-quality Tartary buckwheat for purity and potency.
Market Testing
Continuous product refinement through long-term community tasting activities.
Investment Return Comparison
| Metric | Standard Wheat Noodles | Low GI Soba Noodles |
|---|---|---|
| Glycemic Index | High (70+) | Low (42.7) |
| Blood Sugar Impact | Rapid Rise | Stabilized/Low Rise |
| Fiber Content | Low | High (Satiety Boost) |
| Ingredient Quality | Refined Flour | 70% Buckwheat + Konjac |
| Health Certification | Standard Food | National Patent/Medical Trial |
Frequently Asked Questions
They feature a patented "sugar-blocking" technology and a low GI value of 42.7, which prevents rapid spikes in blood glucose levels.
The GI value is officially tested and certified by the "Beijing Institute of Nutrition Source," a recognized national authority.
Yes, due to the high dietary fiber content and ingredients like konjac, they provide high satiety, helping you eat less while staying full.
The blend includes 70% buckwheat, konjac, green barley, and Tartary buckwheat to ensure nutritional density and low glycemic impact.
Yes, we collaborated with Shanxi Medical University for a three-month clinical trial on diabetic patients, which confirmed the effect of stabilizing blood sugar.
It is ideal for people with chronic conditions like hypertension or diabetes, those focused on fat reduction, and individuals seeking a healthier, sub-health recovery diet.
